Comerica Bank
ITOS

Comerica Bank’s iTeos Therapeutics ITOS Stock Holding History

Comerica Bank’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,243
Closed -$134K – 3783
2023
Q3 		$134K Buy
+12,243
New +$157K ﹤0.01% 2373
2022
Q4 		$282K Sell
14,520
-4,230
-23% -$82.7K ﹤0.01% 1977
2022
Q3 		$351K Buy
18,750
+1,515
+9% +$34.9K ﹤0.01% 1902
2022
Q2 		$453K Buy
17,235
+395
+2% +$9.37K ﹤0.01% 1873
2022
Q1 		$523K Buy
+16,840
New +$612K ﹤0.01% 1852

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Comerica Bank's ITOS Position: Q4 2023 in Review

Comerica Bank sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 12,243 shares — an estimated $134K sold.

Comerica Bank first reported a position in ITOS in Q1 2022 and held it in 5 quarters. The position peaked at $523K in Q1 2022. 137 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Comerica Bank reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Comerica Bank sold 12,243 iTeos Therapeutics shares in Q4 2023, an estimated $134K.
  • Comerica Bank first reported a position in iTeos Therapeutics in Q1 2022 and held it in 5 quarters.
  • Comerica Bank's iTeos Therapeutics position peaked at $523K in Q1 2022.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Comerica Bank's 13F filing for Q4 2023, filed 14 Feb 2024.